Corteva opened higher at $11.53, compared with its previous close of $11.47. In the last trading session, the stock traded between $11.45 and $11.76. It showed a sideways intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Corteva is now worth
$ 26.69
resulting in a loss of
$ 73.31 (73.31%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 14 Analysts
Buy
85.71%
Hold
14.29%
Sell
0%
Markets Today
Today's Change
+$0.05 (+0.39%)
Day High
$11.76
Day Low
$11.45
Day Open
$11.53
Prev Close
$11.47
Volume
1,33,93,672
1W Return
-10.44%
1M Return
-85.21%
3M Return
-87.28%
6M Return
-85.49%
1Y Return
-81.78%
Fundamentals
Market Cap ($ Mn)
7,684
PE Ratio
51.79
PB Ratio
2.22
PEG Ratio
10.24
ROE
4.88%
ROCE
5.56%
EPS (TTM)
$1.74
Investment Returns
1 Week
-10.44%
1 Month
-85.21%
3 Months
-87.28%
6 Months
-85.49%
9 Months
-84.41%
Financials
Quarterly
All values in $ Mn
4.0K
Dec 24
4.4K
Mar 25
6.5K
Jun 25
2.6K
Sep 25
3.9K
Dec 25
6.4K
Jun 26
Updates
10Oct
Corteva stock delivers 15.98% annualized return over past five years
Corteva Inc achieved a 15.98% average annual return over five years. Stock outperformed the market by 3.56% on an annualized basis. A $1,000 investment from five years ago is now worth $2,073.66. Current market capitalization stands at $9.23 billion.
Corteva completed spin-off of seed business into Vylor Inc. Corteva targets $8.4B-$8.7B net sales by 2029, ~3% CAGR. Vylor projects $11.2B-$11.9B net sales by 2029. Corteva aims for >18% EBITDA margin by 2029. Vylor shares rose 2.56%, Corteva fell 5.09% post-spin.
27 days ago
28Sep
Corteva pays $35 million in FTC antitrust settlement over loyalty programs
Corteva agreed to pay $35 million to states as part of an antitrust settlement with the FTC. The settlement bars Corteva from using specific pesticide loyalty programs for 10 years. Regulators cited concerns that the programs harmed competition and raised prices for farmers.
1mo ago
18Sep
Argus Research reiterates Buy on Corteva, keeps $91 target
Argus Research reiterates Buy rating on Corteva Inc. Price target remains at $91 per share. Analyst Alexandra Yates issued the update.
1mo ago
16Sep
Corteva sees FY29 sales of $8.4B-$8.7B
Corteva projects FY29 sales of $8.400 billion-$8.700 billion. Guidance sets revenue bounds for the upcoming fiscal year. No margin or profit data disclosed in this update.
1mo ago
16Sep
Corteva targets $300M gross productivity gains across 2027-2029
Corteva projects $300M in gross productivity benefits from 2027-2029. Net cost improvements expected to exceed $200M after offsets. Residual inflation and tariff impacts concentrated mostly in 2027. Seed-treatment portfolio now valued at $500M, up from $400M.
